| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/1521-4141(200011)30:11<3165::AID-IMMU3165>3.0.CO;2-R |
| P698 | PubMed publication ID | 11093131 |
| P2093 | author name string | I Luescher | |
| P Romero | |||
| B Robert | |||
| J P Mach | |||
| P Guillaume | |||
| P2860 | cites work | Phenotypic analysis of antigen-specific T lymphocytes | Q28290058 |
| Immature Dendritic Cells Phagocytose Apoptotic Cells via αvβ5 and CD36, and Cross-present Antigens to Cytotoxic T Lymphocytes | Q28609747 | ||
| Inhibition of human tumor growth in nude mice by a conjugate of doxorubicin with monoclonal antibodies to epidermal growth factor receptor | Q33858426 | ||
| Critical role for CD8 in T cell receptor binding and activation by peptide/major histocompatibility complex multimers | Q36375751 | ||
| Ex Vivo Staining of Metastatic Lymph Nodes by Class I Major Histocompatibility Complex Tetramers Reveals High Numbers of Antigen-experienced Tumor-specific Cytolytic T Lymphocytes | Q36401622 | ||
| Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance | Q40422790 | ||
| Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease | Q40630247 | ||
| Tumor antigens recognized by T lymphocytes | Q40661131 | ||
| Receptors for HLA class-I molecules in human natural killer cells. | Q41039762 | ||
| Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients | Q41672999 | ||
| Bispecific monoclonal antibodies directed to CD16 and to a tumor-associated antigen induce target-cell lysis by resting NK cells and by a subset of NK clones | Q41684409 | ||
| A New Look at T Cells | Q41896404 | ||
| Radiolabeled fragments of monoclonal antibodies against carcinoembryonic antigen for localization of human colon carcinoma grafted into nude mice | Q42936967 | ||
| High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals | Q42947076 | ||
| Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. | Q47685354 | ||
| Estimation of the frequencies of anti-MAGE-3 cytolytic T-lymphocyte precursors in blood from individuals without cancer | Q47784815 | ||
| Specific targeting of cytotoxic T cells by anti-T3 linked to anti-target cell antibody | Q58192481 | ||
| Immunotoxins: hybrid molecules of monoclonal antibodies and a toxin subunit specifically kill tumour cells | Q59078126 | ||
| Use of radiolabelled monoclonal anti-CEA antibodies for the detection of human carcinomas by external photoscanning and tomoscintigraphy | Q85700494 | ||
| P433 | issue | 11 | |
| P304 | page(s) | 3165-3170 | |
| P577 | publication date | 2000-11-01 | |
| P1433 | published in | European Journal of Immunology | Q5412727 |
| P1476 | title | Antibody-conjugated MHC class I tetramers can target tumor cells for specific lysis by T lymphocytes | |
| P478 | volume | 30 |
| Q77839439 | Anti-viral cytotoxic T cells inhibit the growth of cancer cells with antibody targeted HLA class I/peptide complexes in SCID mice |
| Q37407181 | Antibody-peptide-MHC fusion conjugates target non-cognate T cells to kill tumour cells |
| Q42725940 | Colon cancer and the immune system: the role of tumor invading T cells |
| Q79964508 | Cross-presentation of HLA class I epitopes from influenza matrix protein produced in Saccharomyces cerevisiae |
| Q24792155 | Fully human IgG and IgM antibodies directed against the carcinoembryonic antigen (CEA) Gold 4 epitope and designed for radioimmunotherapy (RIT) of colorectal cancers |
| Q38282953 | Induction of viral and tumour specific CTL responses using antibody targeted HLA class I peptide complexes |
| Q34147847 | MHC/peptide tetramer-based studies of T cell function |
| Q36832141 | Novel antibodies as anticancer agents |
| Q36190463 | Procedure for preparing peptide-major histocompatibility complex tetramers for direct quantification of antigen-specific cytotoxic T lymphocytes |
| Q34834369 | Tumor-specific Ab-mediated targeting of MHC-peptide complexes induces regression of human tumor xenografts in vivo |
Search more.